Results 251 to 260 of about 72,253 (289)

Inhaled Corticosteroid Treatment for Asthma

Allergy and Asthma Proceedings, 1995
Increased numbers of goblet cells associated with decrease in the ciliated epithelium occur at an early stage in the patient with asthma. Recent bronchial biopsy studies have demonstrated that these changes may occur even in the mildest asthmatic patient.
L A, Laitinen, A, Laitinen
openaire   +2 more sources

Inhaled Corticosteroids in Airways Disease

2009
I. Introduction Asthma therapy was revolutionized in the early 1970s by the introduction of inhaled corticosteroid (ICS) therapy. ICS therapy has subsequently proved to be the most effective anti-inflammatory treatments for asthma control. Because of the success of ICS for asthma and the realization that chronic obstructive pulmonary disease (COPD) is ...
Adcock I. M., Chung K. F., CARAMORI, Gaetano   +2 more
openaire   +3 more sources

Acne induced by inhaled corticosteroids

Clinical and Experimental Dermatology, 1993
Four cases of acne apparently induced by inhalation of potent corticosteroids prescribed for the treatment of asthma are described. In one case there appeared to be a dose-dependent relationship. While acne induced by topical or systemic administration of corticosteroids is well recognized, acne following inhaled corticosteroids has not previously been
B, Monk, W J, Cunliffe, A M, Layton, D J, Rhodes   +3 more
openaire   +2 more sources

Inhaled corticosteroids

Annals of Allergy, Asthma & Immunology, 2016
Warner W. Carr, Stanley J. Szefler
openaire   +2 more sources

[Inhaled corticosteroids for COPD].

Nederlands tijdschrift voor geneeskunde, 2003
Over 60% of patients with COPD are treated with inhaled corticosteroids (ICS), even though their use is still subject to debate. The inflammatory process in the lungs of patients with COPD is dominated by macrophages, CD8+ T-lymphocytes, neutrophilic granulocytes and mast cells, as well as an increased production and/or concentration of IL-8, TNF-alpha
openaire   +2 more sources

Advances in inhaled corticosteroid pharmacology

Allergy and Asthma Proceedings, 2007
Inhaled corticosteroids have been the backbone of asthma therapy for the past 20 plus years. Although they have, for the most part, been effective in controlling asthma symptoms and preventing exacerbations, not all patients are universally responsive to their beneficial effects.
openaire   +2 more sources

Inhaled corticosteroid aerosols and candidiasis

British Journal of Diseases of the Chest, 1979
A three-month controlled study was performed to assess the cumulative incidence of oral Candida carriage and thrush in patients starting to take betamethasone valerate aerosol (800 microgram/day) for control of their asthma. Four of 41 patients on the corticosteroid aerosol developed thrush compared with none of 40 in the control group.
J N, Sahay, S S, Chatterjee, T N, Stanbridge   +2 more
openaire   +2 more sources

Comparing inhaled corticosteroids.

Respiratory care, 2000
There are currently available 5 different inhaled corticosteroids, in a variety of different inhalation delivery devices. In the near future there will certainly be more inhaled corticosteroids in newer inhalation delivery devices available in the United States.
openaire   +1 more source

Inhaled corticosteroids: devices and deposition

Paediatric Respiratory Reviews, 2004
Inhaled corticosteroids (ICS) are the most effective anti-inflammatory drugs used today for the prevention and treatment of asthma in children. Recent advances in aerosol delivery including improved formulations of ICS and newer devices present the clinician with an increasing variety of choices when trying to decide what form of ICS therapy is best ...
openaire   +2 more sources

New developments in inhaled corticosteroids

Allergy and Asthma Proceedings, 2006
Inhaled corticosteroids (ICSs) are the foundation of pharmacotherapy in persistent asthma because they control airway inflammation. The anti-inflammatory effect of ICSs is primarily topical, at their site of deposition in the airways. Consequently, deposition characteristics of the ICS and its formulation and inhalation device, in addition to intrinsic
openaire   +2 more sources